

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 4.22697038 |
| 2 | behavioral response to nicotine (GO:0035095) | 4.02741933 |
| 3 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.80657515 |
| 4 | membrane depolarization during action potential (GO:0086010) | 3.54301350 |
| 5 | retinal cone cell development (GO:0046549) | 3.47518171 |
| 6 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 3.42132687 |
| 7 | positive regulation of CREB transcription factor activity (GO:0032793) | 3.39224905 |
| 8 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 3.34037677 |
| 9 | startle response (GO:0001964) | 3.23157415 |
| 10 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 3.17707974 |
| 11 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 3.16027692 |
| 12 | postsynaptic membrane organization (GO:0001941) | 3.12420182 |
| 13 | response to pheromone (GO:0019236) | 3.03659608 |
| 14 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.03368077 |
| 15 | detection of light stimulus involved in sensory perception (GO:0050962) | 3.01870539 |
| 16 | detection of light stimulus involved in visual perception (GO:0050908) | 3.01870539 |
| 17 | neuronal action potential propagation (GO:0019227) | 2.97455687 |
| 18 | positive regulation of phosphoprotein phosphatase activity (GO:0032516) | 2.96053185 |
| 19 | proline transport (GO:0015824) | 2.95644180 |
| 20 | regulation of synapse maturation (GO:0090128) | 2.95467461 |
| 21 | neuron cell-cell adhesion (GO:0007158) | 2.95098506 |
| 22 | gamma-aminobutyric acid transport (GO:0015812) | 2.92138190 |
| 23 | glutamate receptor signaling pathway (GO:0007215) | 2.89397013 |
| 24 | L-fucose catabolic process (GO:0042355) | 2.88571157 |
| 25 | fucose catabolic process (GO:0019317) | 2.88571157 |
| 26 | L-fucose metabolic process (GO:0042354) | 2.88571157 |
| 27 | regulation of hippo signaling (GO:0035330) | 2.87016334 |
| 28 | regulation of action potential (GO:0098900) | 2.85333135 |
| 29 | dendritic spine morphogenesis (GO:0060997) | 2.82019720 |
| 30 | urinary tract smooth muscle contraction (GO:0014848) | 2.80735073 |
| 31 | negative regulation of cAMP-mediated signaling (GO:0043951) | 2.78446594 |
| 32 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 2.77700736 |
| 33 | neuromuscular synaptic transmission (GO:0007274) | 2.74214074 |
| 34 | glycosphingolipid biosynthetic process (GO:0006688) | 2.70849934 |
| 35 | detection of mechanical stimulus involved in sensory perception of sound (GO:0050910) | 2.69891278 |
| 36 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 2.68900901 |
| 37 | negative regulation of reactive oxygen species metabolic process (GO:2000378) | 2.67546113 |
| 38 | regulation of synapse structural plasticity (GO:0051823) | 2.64293199 |
| 39 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 2.61755010 |
| 40 | negative regulation of translation, ncRNA-mediated (GO:0040033) | 2.59908535 |
| 41 | regulation of translation, ncRNA-mediated (GO:0045974) | 2.59908535 |
| 42 | negative regulation of translation involved in gene silencing by miRNA (GO:0035278) | 2.59908535 |
| 43 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan (GO:0019800) | 2.58841896 |
| 44 | auditory behavior (GO:0031223) | 2.58095646 |
| 45 | negative regulation of Rho protein signal transduction (GO:0035024) | 2.57364059 |
| 46 | cAMP catabolic process (GO:0006198) | 2.55733713 |
| 47 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 2.53930946 |
| 48 | macroautophagy (GO:0016236) | 2.53610278 |
| 49 | neuronal action potential (GO:0019228) | 2.53506069 |
| 50 | nephron epithelium morphogenesis (GO:0072088) | 2.53334690 |
| 51 | nephron tubule morphogenesis (GO:0072078) | 2.53334690 |
| 52 | vocalization behavior (GO:0071625) | 2.53311377 |
| 53 | synaptic vesicle maturation (GO:0016188) | 2.52482239 |
| 54 | auditory receptor cell stereocilium organization (GO:0060088) | 2.51992573 |
| 55 | synaptic transmission, glutamatergic (GO:0035249) | 2.51944655 |
| 56 | behavioral response to ethanol (GO:0048149) | 2.49608360 |
| 57 | regulation of neurotransmitter uptake (GO:0051580) | 2.49430550 |
| 58 | cyclic nucleotide catabolic process (GO:0009214) | 2.48512489 |
| 59 | membrane depolarization (GO:0051899) | 2.44961753 |
| 60 | sympathetic nervous system development (GO:0048485) | 2.43766907 |
| 61 | cellular response to ATP (GO:0071318) | 2.43330442 |
| 62 | insulin secretion (GO:0030073) | 2.42917499 |
| 63 | photoreceptor cell development (GO:0042461) | 2.39979886 |
| 64 | potassium ion transmembrane transport (GO:0071805) | 2.39878314 |
| 65 | cellular potassium ion transport (GO:0071804) | 2.39878314 |
| 66 | serotonin metabolic process (GO:0042428) | 2.39520148 |
| 67 | regulation of respiratory system process (GO:0044065) | 2.38818388 |
| 68 | primary amino compound metabolic process (GO:1901160) | 2.38597523 |
| 69 | alanine transport (GO:0032328) | 2.38524425 |
| 70 | photoreceptor cell maintenance (GO:0045494) | 2.36500056 |
| 71 | coenzyme catabolic process (GO:0009109) | 2.36292539 |
| 72 | renal tubule morphogenesis (GO:0061333) | 2.35583937 |
| 73 | positive regulation of synapse maturation (GO:0090129) | 2.33839986 |
| 74 | neurotransmitter-gated ion channel clustering (GO:0072578) | 2.32984220 |
| 75 | potassium ion transport (GO:0006813) | 2.32239177 |
| 76 | positive regulation of fatty acid oxidation (GO:0046321) | 2.31454926 |
| 77 | smooth muscle contraction (GO:0006939) | 2.31377372 |
| 78 | inositol phosphate catabolic process (GO:0071545) | 2.29441421 |
| 79 | eye photoreceptor cell development (GO:0042462) | 2.29372266 |
| 80 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 2.29291913 |
| 81 | phosphorelay signal transduction system (GO:0000160) | 2.28746492 |
| 82 | regulation of energy homeostasis (GO:2000505) | 2.27950619 |
| 83 | ovulation cycle (GO:0042698) | 2.27585486 |
| 84 | cornea development in camera-type eye (GO:0061303) | 2.27363509 |
| 85 | positive regulation of catecholamine secretion (GO:0033605) | 2.26919826 |
| 86 | atrial cardiac muscle cell action potential (GO:0086014) | 2.26291039 |
| 87 | protein import into peroxisome matrix (GO:0016558) | 2.25753225 |
| 88 | spinal cord motor neuron differentiation (GO:0021522) | 2.23414235 |
| 89 | cell migration in hindbrain (GO:0021535) | 2.22411931 |
| 90 | dermatan sulfate metabolic process (GO:0030205) | 2.20717507 |
| 91 | regulation of neurotransmitter transport (GO:0051588) | 2.18923325 |
| 92 | regulation of synaptic transmission, dopaminergic (GO:0032225) | 2.18766273 |
| 93 | cellular ketone body metabolic process (GO:0046950) | 2.17513822 |
| 94 | action potential (GO:0001508) | 2.17021443 |
| 95 | reflex (GO:0060004) | 2.16760653 |
| 96 | opioid receptor signaling pathway (GO:0038003) | 2.16577656 |
| 97 | axoneme assembly (GO:0035082) | 2.16009432 |
| 98 | negative regulation of axon extension involved in axon guidance (GO:0048843) | 2.15822038 |
| 99 | positive regulation of action potential (GO:0045760) | 2.14574469 |
| 100 | negative regulation of mast cell activation (GO:0033004) | 2.14386441 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 3.54764563 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.39636297 |
| 3 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.88831767 |
| 4 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.42221823 |
| 5 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.32064311 |
| 6 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.04952642 |
| 7 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.95391522 |
| 8 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.93809440 |
| 9 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.87877625 |
| 10 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.87736502 |
| 11 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.78684065 |
| 12 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.78495077 |
| 13 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.78155761 |
| 14 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.70655955 |
| 15 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.68101992 |
| 16 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.67775408 |
| 17 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.66305177 |
| 18 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.65863174 |
| 19 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.65602557 |
| 20 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.65413049 |
| 21 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.65031977 |
| 22 | VDR_22108803_ChIP-Seq_LS180_Human | 1.64120356 |
| 23 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.62179627 |
| 24 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.61944530 |
| 25 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.57498277 |
| 26 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.56740320 |
| 27 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.53877055 |
| 28 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.53837689 |
| 29 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.53837689 |
| 30 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.53668385 |
| 31 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.52566723 |
| 32 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.48289247 |
| 33 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.47930102 |
| 34 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.47861413 |
| 35 | * ER_23166858_ChIP-Seq_MCF-7_Human | 1.47364958 |
| 36 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.46245409 |
| 37 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.45593782 |
| 38 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.44656111 |
| 39 | STAT3_23295773_ChIP-Seq_U87_Human | 1.41340745 |
| 40 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.41235293 |
| 41 | P300_19829295_ChIP-Seq_ESCs_Human | 1.39564022 |
| 42 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.37122749 |
| 43 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.36169834 |
| 44 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.36169834 |
| 45 | TCF4_23295773_ChIP-Seq_U87_Human | 1.33911042 |
| 46 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.31501847 |
| 47 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.30443745 |
| 48 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.30364789 |
| 49 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.29647401 |
| 50 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.28969371 |
| 51 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.24175157 |
| 52 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.22815566 |
| 53 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.22634729 |
| 54 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.21391595 |
| 55 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.19631460 |
| 56 | AR_25329375_ChIP-Seq_VCAP_Human | 1.17906124 |
| 57 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.17595121 |
| 58 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.16413105 |
| 59 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.16234933 |
| 60 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.13018708 |
| 61 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.12758733 |
| 62 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.10957977 |
| 63 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.10477584 |
| 64 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.10397225 |
| 65 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.10191054 |
| 66 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.09785572 |
| 67 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.09785572 |
| 68 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.09714221 |
| 69 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.09222094 |
| 70 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.07751408 |
| 71 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.07578708 |
| 72 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.07294888 |
| 73 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.06688402 |
| 74 | * PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.06470325 |
| 75 | FUS_26573619_Chip-Seq_HEK293_Human | 1.05565218 |
| 76 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.04417024 |
| 77 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.03949909 |
| 78 | TP53_16413492_ChIP-PET_HCT116_Human | 1.02746137 |
| 79 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.02222120 |
| 80 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.01743675 |
| 81 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.01123428 |
| 82 | AR_19668381_ChIP-Seq_PC3_Human | 1.00888081 |
| 83 | RXR_22108803_ChIP-Seq_LS180_Human | 1.00643231 |
| 84 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.00606953 |
| 85 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 0.99762394 |
| 86 | ERA_21632823_ChIP-Seq_H3396_Human | 0.98096568 |
| 87 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.97238967 |
| 88 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 0.97157652 |
| 89 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.96250597 |
| 90 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.95829036 |
| 91 | * SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.94695354 |
| 92 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 0.94654967 |
| 93 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 0.94614027 |
| 94 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.94514476 |
| 95 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.93809799 |
| 96 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 0.93345478 |
| 97 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.93180857 |
| 98 | * TBL1_22424771_ChIP-Seq_293T_Human | 0.92124478 |
| 99 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 0.92007787 |
| 100 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 0.91651200 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001968_abnormal_touch/_nociception | 2.63164938 |
| 2 | MP0004859_abnormal_synaptic_plasticity | 2.47705541 |
| 3 | MP0003195_calcinosis | 2.45939078 |
| 4 | MP0003646_muscle_fatigue | 2.43449094 |
| 5 | MP0005551_abnormal_eye_electrophysiolog | 2.30368682 |
| 6 | MP0010386_abnormal_urinary_bladder | 2.29907055 |
| 7 | MP0009046_muscle_twitch | 2.28170737 |
| 8 | MP0001486_abnormal_startle_reflex | 2.24867773 |
| 9 | MP0005423_abnormal_somatic_nervous | 2.20801092 |
| 10 | MP0004885_abnormal_endolymph | 2.12641471 |
| 11 | MP0002272_abnormal_nervous_system | 2.12294436 |
| 12 | MP0005646_abnormal_pituitary_gland | 2.09991024 |
| 13 | MP0003635_abnormal_synaptic_transmissio | 2.07180913 |
| 14 | MP0003880_abnormal_central_pattern | 2.06241514 |
| 15 | MP0000569_abnormal_digit_pigmentation | 2.06196355 |
| 16 | MP0002638_abnormal_pupillary_reflex | 2.05029381 |
| 17 | MP0001986_abnormal_taste_sensitivity | 2.04383961 |
| 18 | MP0009745_abnormal_behavioral_response | 2.03722990 |
| 19 | MP0002736_abnormal_nociception_after | 2.03495436 |
| 20 | MP0005503_abnormal_tendon_morphology | 1.99820860 |
| 21 | MP0003283_abnormal_digestive_organ | 1.94283319 |
| 22 | MP0001501_abnormal_sleep_pattern | 1.87311623 |
| 23 | MP0002837_dystrophic_cardiac_calcinosis | 1.87265195 |
| 24 | MP0002064_seizures | 1.77421124 |
| 25 | MP0002063_abnormal_learning/memory/cond | 1.74943365 |
| 26 | MP0002572_abnormal_emotion/affect_behav | 1.74107450 |
| 27 | MP0001984_abnormal_olfaction | 1.73561224 |
| 28 | MP0004043_abnormal_pH_regulation | 1.71775387 |
| 29 | MP0005171_absent_coat_pigmentation | 1.70405574 |
| 30 | MP0001502_abnormal_circadian_rhythm | 1.70305022 |
| 31 | MP0002735_abnormal_chemical_nociception | 1.66268535 |
| 32 | MP0003879_abnormal_hair_cell | 1.66126739 |
| 33 | MP0005253_abnormal_eye_physiology | 1.63047614 |
| 34 | MP0001958_emphysema | 1.60837194 |
| 35 | MP0002102_abnormal_ear_morphology | 1.60132238 |
| 36 | MP0006276_abnormal_autonomic_nervous | 1.56264012 |
| 37 | MP0002557_abnormal_social/conspecific_i | 1.47467467 |
| 38 | MP0006072_abnormal_retinal_apoptosis | 1.43264283 |
| 39 | MP0001970_abnormal_pain_threshold | 1.41790724 |
| 40 | MP0005174_abnormal_tail_pigmentation | 1.40704469 |
| 41 | MP0005377_hearing/vestibular/ear_phenot | 1.39422382 |
| 42 | MP0003878_abnormal_ear_physiology | 1.39422382 |
| 43 | MP0005645_abnormal_hypothalamus_physiol | 1.37950419 |
| 44 | MP0003136_yellow_coat_color | 1.36722470 |
| 45 | MP0002734_abnormal_mechanical_nocicepti | 1.35401989 |
| 46 | MP0002822_catalepsy | 1.33768499 |
| 47 | MP0004145_abnormal_muscle_electrophysio | 1.32927192 |
| 48 | MP0001485_abnormal_pinna_reflex | 1.32180939 |
| 49 | MP0002876_abnormal_thyroid_physiology | 1.31957178 |
| 50 | MP0000013_abnormal_adipose_tissue | 1.26544473 |
| 51 | MP0002733_abnormal_thermal_nociception | 1.25154918 |
| 52 | MP0003137_abnormal_impulse_conducting | 1.23876888 |
| 53 | MP0002067_abnormal_sensory_capabilities | 1.23721083 |
| 54 | MP0002108_abnormal_muscle_morphology | 1.23129419 |
| 55 | MP0005386_behavior/neurological_phenoty | 1.22499366 |
| 56 | MP0004924_abnormal_behavior | 1.22499366 |
| 57 | MP0004215_abnormal_myocardial_fiber | 1.21314540 |
| 58 | MP0004130_abnormal_muscle_cell | 1.19660135 |
| 59 | MP0008877_abnormal_DNA_methylation | 1.18140616 |
| 60 | MP0001963_abnormal_hearing_physiology | 1.16746481 |
| 61 | MP0003279_aneurysm | 1.14970713 |
| 62 | MP0000751_myopathy | 1.14728804 |
| 63 | MP0004084_abnormal_cardiac_muscle | 1.14388705 |
| 64 | MP0001756_abnormal_urination | 1.13365909 |
| 65 | MP0009780_abnormal_chondrocyte_physiolo | 1.11786251 |
| 66 | MP0008438_abnormal_cutaneous_collagen | 1.11740221 |
| 67 | MP0004142_abnormal_muscle_tone | 1.11069366 |
| 68 | MP0004085_abnormal_heartbeat | 1.10357843 |
| 69 | MP0000631_abnormal_neuroendocrine_gland | 1.04147344 |
| 70 | MP0004036_abnormal_muscle_relaxation | 1.04073981 |
| 71 | MP0002229_neurodegeneration | 1.04002077 |
| 72 | MP0000538_abnormal_urinary_bladder | 1.01795391 |
| 73 | MP0000427_abnormal_hair_cycle | 0.99355690 |
| 74 | MP0002184_abnormal_innervation | 0.97395907 |
| 75 | MP0000026_abnormal_inner_ear | 0.97267604 |
| 76 | MP0004133_heterotaxia | 0.96838118 |
| 77 | MP0005167_abnormal_blood-brain_barrier | 0.95539759 |
| 78 | MP0001346_abnormal_lacrimal_gland | 0.93930135 |
| 79 | MP0002882_abnormal_neuron_morphology | 0.93107628 |
| 80 | MP0003633_abnormal_nervous_system | 0.91757976 |
| 81 | MP0005195_abnormal_posterior_eye | 0.91401630 |
| 82 | MP0004742_abnormal_vestibular_system | 0.91367596 |
| 83 | MP0003045_fibrosis | 0.90619876 |
| 84 | MP0000015_abnormal_ear_pigmentation | 0.90093958 |
| 85 | MP0002752_abnormal_somatic_nervous | 0.89651209 |
| 86 | MP0002909_abnormal_adrenal_gland | 0.87670965 |
| 87 | MP0000230_abnormal_systemic_arterial | 0.87611764 |
| 88 | MP0003787_abnormal_imprinting | 0.86560267 |
| 89 | MP0001299_abnormal_eye_distance/ | 0.86063224 |
| 90 | MP0001324_abnormal_eye_pigmentation | 0.85744571 |
| 91 | MP0000778_abnormal_nervous_system | 0.85408075 |
| 92 | MP0001664_abnormal_digestion | 0.85253596 |
| 93 | MP0001905_abnormal_dopamine_level | 0.83886425 |
| 94 | MP0000372_irregular_coat_pigmentation | 0.83250169 |
| 95 | MP0004270_analgesia | 0.82459108 |
| 96 | MP0002066_abnormal_motor_capabilities/c | 0.79022440 |
| 97 | MP0005187_abnormal_penis_morphology | 0.78365219 |
| 98 | MP0005620_abnormal_muscle_contractility | 0.78120971 |
| 99 | MP0008872_abnormal_physiological_respon | 0.75596322 |
| 100 | MP0004381_abnormal_hair_follicle | 0.74533595 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Congenital stationary night blindness (HP:0007642) | 4.78605727 |
| 2 | Genetic anticipation (HP:0003743) | 4.32136912 |
| 3 | Attenuation of retinal blood vessels (HP:0007843) | 3.53852468 |
| 4 | Febrile seizures (HP:0002373) | 3.45699770 |
| 5 | Abnormality of midbrain morphology (HP:0002418) | 3.40217640 |
| 6 | Molar tooth sign on MRI (HP:0002419) | 3.40217640 |
| 7 | Progressive cerebellar ataxia (HP:0002073) | 3.17672391 |
| 8 | Protruding tongue (HP:0010808) | 3.16037987 |
| 9 | Hyperventilation (HP:0002883) | 3.01508076 |
| 10 | Gaze-evoked nystagmus (HP:0000640) | 3.00798395 |
| 11 | Type II lissencephaly (HP:0007260) | 2.99315759 |
| 12 | Pancreatic cysts (HP:0001737) | 2.96236662 |
| 13 | Focal seizures (HP:0007359) | 2.88131961 |
| 14 | Nephronophthisis (HP:0000090) | 2.85995332 |
| 15 | Cerebellar dysplasia (HP:0007033) | 2.75601720 |
| 16 | Atonic seizures (HP:0010819) | 2.73569972 |
| 17 | Keratoconus (HP:0000563) | 2.72544535 |
| 18 | Increased corneal curvature (HP:0100692) | 2.72544535 |
| 19 | Polydipsia (HP:0001959) | 2.72277061 |
| 20 | Abnormal drinking behavior (HP:0030082) | 2.72277061 |
| 21 | Chronic hepatic failure (HP:0100626) | 2.64252802 |
| 22 | Decreased central vision (HP:0007663) | 2.63503790 |
| 23 | Clumsiness (HP:0002312) | 2.63482866 |
| 24 | Tubular atrophy (HP:0000092) | 2.58783629 |
| 25 | Abnormality of the renal cortex (HP:0011035) | 2.55305391 |
| 26 | Congenital sensorineural hearing impairment (HP:0008527) | 2.50997158 |
| 27 | Abnormality of the renal medulla (HP:0100957) | 2.45935201 |
| 28 | Intestinal atresia (HP:0011100) | 2.45508203 |
| 29 | Epileptic encephalopathy (HP:0200134) | 2.44182301 |
| 30 | Cystic liver disease (HP:0006706) | 2.43472540 |
| 31 | Prolonged QT interval (HP:0001657) | 2.43283031 |
| 32 | Bony spicule pigmentary retinopathy (HP:0007737) | 2.40139741 |
| 33 | Absent speech (HP:0001344) | 2.40056288 |
| 34 | Flat cornea (HP:0007720) | 2.34338969 |
| 35 | Bulbous nose (HP:0000414) | 2.33307921 |
| 36 | Focal motor seizures (HP:0011153) | 2.33177356 |
| 37 | Pancreatic fibrosis (HP:0100732) | 2.32332055 |
| 38 | True hermaphroditism (HP:0010459) | 2.31353483 |
| 39 | Arthropathy (HP:0003040) | 2.29698819 |
| 40 | Hypoplastic ischia (HP:0003175) | 2.28079043 |
| 41 | Progressive inability to walk (HP:0002505) | 2.27314813 |
| 42 | Abolished electroretinogram (ERG) (HP:0000550) | 2.22761867 |
| 43 | Inability to walk (HP:0002540) | 2.19588139 |
| 44 | Dialeptic seizures (HP:0011146) | 2.13269850 |
| 45 | Absence seizures (HP:0002121) | 2.10194147 |
| 46 | Broad-based gait (HP:0002136) | 2.08159441 |
| 47 | Morphological abnormality of the middle ear (HP:0008609) | 2.05445520 |
| 48 | Hypothermia (HP:0002045) | 2.04853337 |
| 49 | Hemiparesis (HP:0001269) | 2.04074647 |
| 50 | Fetal akinesia sequence (HP:0001989) | 2.01390283 |
| 51 | Supernumerary spleens (HP:0009799) | 1.99945238 |
| 52 | Polyuria (HP:0000103) | 1.97363400 |
| 53 | Anterior segment dysgenesis (HP:0007700) | 1.97292216 |
| 54 | Renovascular hypertension (HP:0100817) | 1.96241007 |
| 55 | Abnormality of the ischium (HP:0003174) | 1.94842586 |
| 56 | Abnormal rod and cone electroretinograms (HP:0008323) | 1.93072194 |
| 57 | Short chin (HP:0000331) | 1.92957626 |
| 58 | Lissencephaly (HP:0001339) | 1.92657017 |
| 59 | Atrial fibrillation (HP:0005110) | 1.90725572 |
| 60 | Facial diplegia (HP:0001349) | 1.87233006 |
| 61 | Aortic aneurysm (HP:0004942) | 1.86433117 |
| 62 | Obstructive sleep apnea (HP:0002870) | 1.86373046 |
| 63 | Epileptiform EEG discharges (HP:0011182) | 1.85235815 |
| 64 | Annular pancreas (HP:0001734) | 1.84888267 |
| 65 | Retinal dysplasia (HP:0007973) | 1.82454916 |
| 66 | Abnormal EKG (HP:0003115) | 1.80326109 |
| 67 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 1.80103152 |
| 68 | Pachygyria (HP:0001302) | 1.79883918 |
| 69 | EEG with generalized epileptiform discharges (HP:0011198) | 1.79309551 |
| 70 | Primary atrial arrhythmia (HP:0001692) | 1.79212196 |
| 71 | Chorioretinal atrophy (HP:0000533) | 1.79043050 |
| 72 | Wrist flexion contracture (HP:0001239) | 1.78396228 |
| 73 | Bowel diverticulosis (HP:0005222) | 1.77948013 |
| 74 | Constricted visual fields (HP:0001133) | 1.77710229 |
| 75 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 1.76605207 |
| 76 | Hypoplasia of the fovea (HP:0007750) | 1.76605207 |
| 77 | Urinary bladder sphincter dysfunction (HP:0002839) | 1.74854934 |
| 78 | Amblyopia (HP:0000646) | 1.74354557 |
| 79 | Central scotoma (HP:0000603) | 1.74278123 |
| 80 | Depressed nasal tip (HP:0000437) | 1.73659489 |
| 81 | Macroglossia (HP:0000158) | 1.73582797 |
| 82 | Decreased circulating renin level (HP:0003351) | 1.73103231 |
| 83 | Medial flaring of the eyebrow (HP:0010747) | 1.72858282 |
| 84 | Congenital hepatic fibrosis (HP:0002612) | 1.72623166 |
| 85 | Hypoventilation (HP:0002791) | 1.71203691 |
| 86 | Action tremor (HP:0002345) | 1.70040173 |
| 87 | Bradycardia (HP:0001662) | 1.68703264 |
| 88 | Small hand (HP:0200055) | 1.68162674 |
| 89 | Optic nerve hypoplasia (HP:0000609) | 1.67945280 |
| 90 | Posterior subcapsular cataract (HP:0007787) | 1.67187296 |
| 91 | Type II diabetes mellitus (HP:0005978) | 1.66610136 |
| 92 | Pendular nystagmus (HP:0012043) | 1.65686394 |
| 93 | Abnormality of the right ventricle (HP:0001707) | 1.65393332 |
| 94 | Abnormal eating behavior (HP:0100738) | 1.64923382 |
| 95 | Large for gestational age (HP:0001520) | 1.64500469 |
| 96 | Infantile muscular hypotonia (HP:0008947) | 1.63715207 |
| 97 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 1.62479351 |
| 98 | Bladder diverticulum (HP:0000015) | 1.62312372 |
| 99 | Hypsarrhythmia (HP:0002521) | 1.61163091 |
| 100 | Renal cortical cysts (HP:0000803) | 1.61077593 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FRK | 5.67278858 |
| 2 | PINK1 | 3.93294476 |
| 3 | ADRBK2 | 3.12365282 |
| 4 | INSRR | 2.93170253 |
| 5 | DAPK2 | 2.43956066 |
| 6 | BMPR1B | 2.11478560 |
| 7 | GRK1 | 2.02081246 |
| 8 | MARK1 | 2.02045058 |
| 9 | TLK1 | 1.84252288 |
| 10 | MAP3K7 | 1.83730352 |
| 11 | CASK | 1.81245474 |
| 12 | MUSK | 1.80623598 |
| 13 | MAPK13 | 1.78830538 |
| 14 | NTRK3 | 1.73893260 |
| 15 | ACVR1B | 1.69097443 |
| 16 | AKT3 | 1.68025988 |
| 17 | PRKD3 | 1.60701786 |
| 18 | WNK4 | 1.54353760 |
| 19 | SIK2 | 1.49084922 |
| 20 | WNK3 | 1.45035785 |
| 21 | MYLK | 1.39906543 |
| 22 | ZAK | 1.38575465 |
| 23 | ADRBK1 | 1.33989544 |
| 24 | NTRK2 | 1.33446211 |
| 25 | TAOK3 | 1.31387274 |
| 26 | NUAK1 | 1.20875938 |
| 27 | PAK3 | 1.19018746 |
| 28 | PRKD2 | 1.17842803 |
| 29 | PAK6 | 1.17308355 |
| 30 | PRKCH | 1.14998659 |
| 31 | CAMK1 | 1.11045837 |
| 32 | CAMK1D | 1.03809063 |
| 33 | SGK494 | 1.00100368 |
| 34 | SGK223 | 1.00100368 |
| 35 | PRKCE | 1.00015367 |
| 36 | FGFR2 | 0.99788278 |
| 37 | SGK2 | 0.98213146 |
| 38 | PRKCG | 0.97372952 |
| 39 | STK38 | 0.97030192 |
| 40 | OBSCN | 0.94337254 |
| 41 | MAP4K2 | 0.93087335 |
| 42 | CAMKK1 | 0.90820593 |
| 43 | PRKAA1 | 0.90336950 |
| 44 | PHKG2 | 0.89101451 |
| 45 | PHKG1 | 0.89101451 |
| 46 | CDC42BPA | 0.85038575 |
| 47 | NEK2 | 0.83928697 |
| 48 | TNIK | 0.83633885 |
| 49 | EPHA3 | 0.83473705 |
| 50 | PKN1 | 0.82873987 |
| 51 | MARK2 | 0.82025056 |
| 52 | CAMKK2 | 0.80967062 |
| 53 | CAMK4 | 0.78135556 |
| 54 | WNK1 | 0.77092501 |
| 55 | PTK2B | 0.75873804 |
| 56 | ROCK1 | 0.75843879 |
| 57 | OXSR1 | 0.75524271 |
| 58 | CAMK2A | 0.74036670 |
| 59 | STK11 | 0.72475075 |
| 60 | MARK3 | 0.72274712 |
| 61 | PRKAA2 | 0.70165556 |
| 62 | MAPK15 | 0.70117035 |
| 63 | KIT | 0.69073833 |
| 64 | TXK | 0.67892407 |
| 65 | MAPK12 | 0.63216544 |
| 66 | DDR2 | 0.62107327 |
| 67 | TNK2 | 0.61139580 |
| 68 | UHMK1 | 0.60521094 |
| 69 | NLK | 0.59223122 |
| 70 | LATS1 | 0.58770265 |
| 71 | MKNK2 | 0.57082444 |
| 72 | TIE1 | 0.55720653 |
| 73 | MAP3K4 | 0.55552866 |
| 74 | CSNK1A1L | 0.55279879 |
| 75 | CHUK | 0.54289537 |
| 76 | PLK2 | 0.53601117 |
| 77 | PRKCZ | 0.53020562 |
| 78 | STK39 | 0.52330462 |
| 79 | CSNK1G1 | 0.51925239 |
| 80 | MAP2K6 | 0.50607063 |
| 81 | TGFBR1 | 0.47660615 |
| 82 | HIPK2 | 0.47503077 |
| 83 | CAMK2B | 0.46500685 |
| 84 | CAMK1G | 0.46134058 |
| 85 | RPS6KA6 | 0.44734483 |
| 86 | CDK5 | 0.43937207 |
| 87 | EPHA4 | 0.43414549 |
| 88 | PRKG1 | 0.42865472 |
| 89 | CSNK1G2 | 0.42591144 |
| 90 | RPS6KA2 | 0.40946655 |
| 91 | PRKACA | 0.40848255 |
| 92 | CSNK1G3 | 0.37368851 |
| 93 | SGK3 | 0.37136552 |
| 94 | MAP2K7 | 0.36680429 |
| 95 | TRPM7 | 0.35454932 |
| 96 | TYRO3 | 0.34168653 |
| 97 | CDK3 | 0.33967395 |
| 98 | RPS6KA3 | 0.32176053 |
| 99 | CAMK2D | 0.32001190 |
| 100 | CSNK1D | 0.31917159 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nicotine addiction_Homo sapiens_hsa05033 | 3.17428915 |
| 2 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 2.99347336 |
| 3 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 2.83783275 |
| 4 | Phototransduction_Homo sapiens_hsa04744 | 2.42050191 |
| 5 | Taste transduction_Homo sapiens_hsa04742 | 2.33246232 |
| 6 | Morphine addiction_Homo sapiens_hsa05032 | 2.28547530 |
| 7 | Circadian entrainment_Homo sapiens_hsa04713 | 2.20482078 |
| 8 | Insulin secretion_Homo sapiens_hsa04911 | 2.18376078 |
| 9 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 2.15810571 |
| 10 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.14165613 |
| 11 | GABAergic synapse_Homo sapiens_hsa04727 | 2.02657877 |
| 12 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.92256372 |
| 13 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.87074391 |
| 14 | Olfactory transduction_Homo sapiens_hsa04740 | 1.86627661 |
| 15 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.63765748 |
| 16 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.59355936 |
| 17 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.57957215 |
| 18 | Circadian rhythm_Homo sapiens_hsa04710 | 1.53612584 |
| 19 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.52244503 |
| 20 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.51929065 |
| 21 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.50316109 |
| 22 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.46486920 |
| 23 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.43409662 |
| 24 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.42234776 |
| 25 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.40202906 |
| 26 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.39404996 |
| 27 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.35865492 |
| 28 | ABC transporters_Homo sapiens_hsa02010 | 1.35105840 |
| 29 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.34318814 |
| 30 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.34023515 |
| 31 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.31945513 |
| 32 | Cocaine addiction_Homo sapiens_hsa05030 | 1.31769180 |
| 33 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.26708855 |
| 34 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 1.25777636 |
| 35 | Salivary secretion_Homo sapiens_hsa04970 | 1.22756085 |
| 36 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.21339176 |
| 37 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.10893512 |
| 38 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.10725170 |
| 39 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.07980435 |
| 40 | Renin secretion_Homo sapiens_hsa04924 | 1.04284440 |
| 41 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.03645686 |
| 42 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.02238077 |
| 43 | Lysine degradation_Homo sapiens_hsa00310 | 0.95246755 |
| 44 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.93814856 |
| 45 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.93504435 |
| 46 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.93140880 |
| 47 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.91860332 |
| 48 | Long-term depression_Homo sapiens_hsa04730 | 0.91174347 |
| 49 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.89763219 |
| 50 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.85151051 |
| 51 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.83816806 |
| 52 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.82736831 |
| 53 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.81781459 |
| 54 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.79706660 |
| 55 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.79434129 |
| 56 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.78034328 |
| 57 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.77677130 |
| 58 | Long-term potentiation_Homo sapiens_hsa04720 | 0.77116594 |
| 59 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.73010813 |
| 60 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.69959370 |
| 61 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.69038404 |
| 62 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.65190859 |
| 63 | Axon guidance_Homo sapiens_hsa04360 | 0.62905014 |
| 64 | Melanogenesis_Homo sapiens_hsa04916 | 0.61391716 |
| 65 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.58714713 |
| 66 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.58518358 |
| 67 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.57229837 |
| 68 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.55759203 |
| 69 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.54974144 |
| 70 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.52761301 |
| 71 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.51363014 |
| 72 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.50225704 |
| 73 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.48872051 |
| 74 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.47985314 |
| 75 | Melanoma_Homo sapiens_hsa05218 | 0.47128482 |
| 76 | Bile secretion_Homo sapiens_hsa04976 | 0.46077970 |
| 77 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.45760194 |
| 78 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.45662363 |
| 79 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.44758103 |
| 80 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.44231960 |
| 81 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.43584413 |
| 82 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.43530458 |
| 83 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.43524529 |
| 84 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.43515955 |
| 85 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.43477873 |
| 86 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.42861713 |
| 87 | Basal transcription factors_Homo sapiens_hsa03022 | 0.42002554 |
| 88 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.40261147 |
| 89 | Insulin resistance_Homo sapiens_hsa04931 | 0.39868850 |
| 90 | Mineral absorption_Homo sapiens_hsa04978 | 0.39732994 |
| 91 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.39343927 |
| 92 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.36890681 |
| 93 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.36670386 |
| 94 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.35990719 |
| 95 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.35843759 |
| 96 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.34532169 |
| 97 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.32282182 |
| 98 | Focal adhesion_Homo sapiens_hsa04510 | 0.31891798 |
| 99 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.31745210 |
| 100 | Alcoholism_Homo sapiens_hsa05034 | 0.30841235 |

